{
    "2020-06-26": [
        [
            {
                "time": "2023-10-05",
                "original_text": "EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Novartis AG â€“ NVS",
                "features": {
                    "keywords": [
                        "Rosen Law Firm",
                        "Investigation",
                        "Securities Claims",
                        "Novartis AG"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "How gene therapy and CRISPR are helping to cure blindness",
                "features": {
                    "keywords": [
                        "gene therapy",
                        "CRISPR",
                        "cure blindness"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novartis faces key meeting in U.S. bribery scandal after settling corruption case",
                "features": {
                    "keywords": [
                        "Novartis",
                        "bribery scandal",
                        "corruption case"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "ESG strategies still buoyant despite Covid, say in-house lawyers",
                "features": {
                    "keywords": [
                        "ESG strategies",
                        "Covid",
                        "in-house lawyers"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "sustainability",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}